当科についてAbout

当科の業績

和文論文・著書
  • 新木　健一郎、調　憲、齊藤　文良、桑野　博行. 外傷性胆汁漏の治療. 臨床外科71(7)821-825,2016
  • 新木　健一郎、調　憲、久保　憲生、渡辺　亮、五十嵐　隆通、塚越　真梨子、桑野　博行.　GIST肝転移. 臨床外科. 71(12)1366-1371, 2016
  • 調　憲、新木　健一郎、平井　圭太郎、久保　憲生、渡辺　亮、星野　弘毅、桑野　博行. 肝臓外科における周術期栄養管理の実際. 臨床栄養128(7)912-916, 2016
  • 調　憲、新木　健一郎、久保　憲生、播本　憲史、池上　徹、吉住　朋晴、伊藤　心二、桑野　博行、前原　喜彦. サルコペニアと外科. 臨床外科71(6)748-753, 2016
  • 齊藤　文良、新木　健一郎、石井　範洋、塚越　真梨子、渡辺　亮、久保　憲生、伊古田　勇人、調　憲、桑野　博行.IgG4関連硬化性胆管炎の組織所見を伴った下部胆管癌の1切除例.胆道30(5)864-869,2016
  • 調　憲、新木　健一郎、塚越　真梨子．肝疾患におけるサルコペニア研究の現状と今後の展開．日消誌 114:826-33, 2017.
  • 新木　健一郎、調　憲、塚越　真梨子、桑野　博行．肝胆膵がん患者における特有の栄養異常とサルコペニアを背景においた術前栄養管理の意義．栄養経営エキスパート2017:7:31-34.
  • 山中　崇弘、新木　健一郎、石井　範洋、塚越　真梨子、五十嵐　隆通、渡辺　亮、久保　憲生、大島　清宏、桑野　博行、調　憲．侵襲性クエブシエラ感染症の1救命例。日本腹部救急医学会雑誌37：931-4、2017．
  • 新木　健一郎、調　憲、久保　憲生、渡辺　亮、桑野　博行
    手術ステップごとに理解する標準術式アトラス：中央二区域切除. 臨床外科 72(7); 11:202-207. 2017
  • 五十嵐　隆通、新木　健一郎、山中　崇弘、萩原　慶、石井　範洋、塚越　真梨子、渡辺　亮、久保　憲生、播本　憲史、調　憲、桑野　博行、柴　慎太郎、入江　大介、岡本　雅彦、加藤　弘之、清原　浩樹、大野　達也、中野　隆史．局所進行膵癌に対するGemcitabine併用重粒子線治療．癌の臨床63(5)455-459, 2017
  • 調　憲、塚越　真梨子、播本　憲史．NASH/NAFLDにおけるサルコペニアの関与．肝胆膵　76(4)；576-581; 2018
  • 山中　崇弘、新木　健一郎、石井　範洋、塚越　真梨子、五十嵐　隆通、渡辺　亮、久保　憲生、播本　憲史、渋谷　圭、大島　清宏、桑野　博行、調　憲．集学的治療で救命し得た、肝膿瘍による門脈血栓症の1例。日本腹部救急医学会雑誌38(7)：1189-93． 2018．
  • 調　憲 肝胆膵外科における核医学診断の意義 群馬県核医学研究会会誌 2018：33：25－28
  • 播本　憲史、新木健一郎、調 憲　手術の基礎知識　縫合糸の基本　消化器外科手術　基本編 (秀潤社)　p10-22　2019
  • 播本　憲史、調 憲、塚越 真梨子　サルコペニアとNAFLD/NASH　日本臨牀　77(5):878-883;2019
  • 塚越　真梨子 膵切除における術前握力評価の意義とリハビリテーション栄養の効果　臨床栄養　第136巻　第1号　2020．
  • 播本　憲史、調　憲　『ここがキモ！いまはこうする 肝疾患 vs 薬物療法』　月間薬事Vol. 62 No.2　2020．
  • 奥山　隆之、新木　健一郎、山中　崇弘、石井　範洋、塚越　真梨子、五十嵐　隆通、渡辺　亮、久保　憲生、播本　憲史、調　憲．腹腔鏡下胆嚢摘出術による肝門部胆管・右肝動脈の合併損傷に対して肝右葉切除を施行した1例．日本外科系連合学会誌、45(2)：134-139，2020.
  • 播本　憲史、調　憲　混合型肝癌の臨床　肝胆膵　80(4):673-678;2020
  • 関　貴臣、播本　憲史、新木　健一郎、渡辺　亮、伊古田　勇人、調　憲、集学的治療を行った肝細胞癌・混合型肝癌の一例　日本臨床外科学会雑誌81（４）、736-742、2020
  • 調　憲、播本憲史、小山　洋．　都道府県ごとの新型コロナウイルス(COVID-19)累積感染割合と人口密集度の批評との関連に関する研究． KMJ THE KITAKANTO MEDICAL JOURNAL 2020; 70: 235-242.
  • 調　憲、治療選択時，COVID-19感染を恐れ手術より化学療法を選択する患者・家族への支援． 看護技術 2020; 66(14): 30-33.
  • 調　憲、群馬の地で新たな外科学講座の道を歩む。九大医学部同窓会誌　学士鍋　第197号 2020.
  • 調　憲、新木健一郎　新型コロナウイルス感染症(COVID-19)流行におけるがん医療の影響～外科の立場から　癌と化学療法 2020; 47(12): 1668-71
  • 調　憲、久保憲生　COVID-19感染まん延時の肝胆膵外科 −提言と現状−　肝胆膵 2020;81 (6): 1117-22.
  • 新木健一郎，五十嵐隆通，渡辺 亮，久保憲生，播本憲史, 調　憲．膵頭十二指腸切除術後Braun吻合の腸間膜間隙に発生した内ヘルニアの１例． 日本臨床外科学会雑誌　82（3）; 646-651: 2021
  • 新木健一郎、播本憲史、久保憲生、渡辺 亮、五十嵐隆通、塚越真梨子、石井範洋、調　憲．肝細胞癌に対する腹腔鏡下肝切除―尾状葉病変への適応と手術手技について―． 肝胆膵　82(5); 689-695: 2021
  • 調　憲、佐伯浩司、宮崎達也、小川哲史、蒔田富士雄、設楽芳範、町田昌巳、保田尚邦、加藤広行、尾嶋　仁、細内康男、内藤　浩、龍城宏典、内田信之、岩波弘太郎、郡隆之、林浩二、岩崎茂、小山洋.　COVID-19感染拡大下における群馬県がん手術症例数の減少：2020年1～9月の集計結果．日外会誌 2021; 122: 352-358.
  • 新木健一郎、播本憲史、渡辺亮、塚越真梨子、石井範洋、萩原慶、山中崇弘、調　憲．肝胆膵癌におけるconversion surgery．言葉の定義―induction, rescue, salvage, adjuvantとの違い―．肝胆膵 84(5)：561-564, 2022
  • 新木健一郎、石井範洋、塚越真梨子、渡辺亮、播本憲史、岩﨑広英、調　憲．腹腔鏡下肝切除におけるカダバートレーニングを利用した新規術式導入と教育の意義．臨床外科 78(3): 319-324. 2023
  • 新木健一郎、中澤信博、石井範洋、塚越真梨子、五十嵐隆通、播本憲史、岩﨑広英、調　憲．腹腔鏡下肝切除におけるカダバートレーニングの教育的意義．臨床雑誌外科 86(3): 255-263. 2024.
  • 新木健一郎、調　憲．外科・手術のキホン 第3章 臓器別の代表的な手術とその考えかた 6．肝臓．レジデントノート増刊 26(5): 170(904)-180(914). 2024
英文論文・著書
  • Ishii N, Araki K, Yokobori T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hirai K, Shirabe K, Kuwano H. Presence of Cytokeratin 19-Expressing Cholangiocarcinoma-Like Tumour in a Liver Metastatic Lesion of Rectal Neuroendocrine Tumour. Case Rep Gastroenterol. 2016 Aug 12;10(2):431-439.
  • Tsukagoshi M, Satoshi Wada, Takehiko Yokobori, Bolag Altan, Norihiro Ishii, Akira Watanabe, Norio Kubo, Fumiyoshi Saito, Kenichiro Araki, Hideki Suzuki, Yasuo Hosouchi, and Hiroyuki Kuwano. Overexpression of natural killer group 2 member D ligands Predicts favorable prognosis in cholangiocarcinoma. Cancer Science.107:116-122,2016
  • Tsukagoshi M, Hosouchi Y, Araki K, Mochida Y, Aihara R, Shirabe K, Kuwano H. Neuroendocrine tumor of the ampulla of Vater with distant cystic lymph node metastasis: a case report. Surg Case Rep. 2016 Dec;2(1):73.
  • Kubo N, Araki K, Kuwano H, Shirabe K. Cancer-associated fibroblasts in hepatocellular carcinoma. World J Gastroenterol. 2016 Aug 14;22(30):6841-50.
  • Watanabe A, Araki K, Hirai K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Hoshino K, Kuwano H, Shirabe K. A Novel Clinical Factor, D-Dimer Platelet Multiplication, May Predict Postoperative Recurrence and Prognosis for Patients with Cholangiocarcinoma. Ann Surg Oncol. 2016 Dec;23(Suppl 5):886-891.
  • Araki K, Fuks D, Nomi T, Ogiso S, Lozano RR, Kuwano H, Gayet B. Feasibility of laparoscopic liver resection for caudate lobe: technical strategy and comparative analysis with anteroinferior and posterosuperior segments. Surg Endosc. 2016 Oct;30(10).
  • Saito F, Araki K, Yokobori T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Altan B, Shirabe K, Kuwano H. High expression of karyopherin-α2 and stathmin 1 is associated with proliferation potency and transformation in the bile duct and gall bladder epithelia in the cases of pancreaticobiliary maljunction. J Surg Oncol. 2016 Sep;114(4):462-8.
  • Igarashi T, Araki K, Yokobori T, Altan B, Yamanaka T, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Handa T, Hosouchi Y, Nishiyama M, Oyama T, Shirabe K, Kuwano H. Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression. Oncotarget. 2017 Jan 17. doi: 10.18632/oncotarget.14703. [Epub ahead of print]
  • Tsukagoshi M, Araki K, Yokobori T, Altan B, Suzuki H, Kubo N, Watanabe A, Ishii N, Hosouchi Y, Nishiyama M, Shirabe K, Kuwano H. Overexpression of karyopherin-a2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins. Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15020. [Epub ahead of print]
  • Kubo N, Araki K, Yamanaka T, Hoshino K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Hirai K, Saitoh F, Kuwano H, Shirabe K. Perioperative management of hepatectomy in patients with interstitial pneumonia: a report of three cases and a literature review. Surg Today. 2017 Mar 1. doi: 10.1007/s00595-017-1489-7. [Epub ahead of print] Review.
  • Muranushi R, Suzuki M, Araki K, Kubo N, Otake S, Nishida Y, Ishige T, Arakawa H, Kuwano H, Shirabe K.Successful hepatectomy for hepatic abscess with chronic granulomatous disease: a case report.　Surg Case Rep. 2017 Dec;3(1):57. doi: 10.1186/s40792-017-0333-z. Epub 2017 Apr 26.　PMID:28447322.
  • Kubo N, Araki K, Altan B, Hoshino K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kato T, Hirai K, Yokobori T, Saito F, Suzuki H, Kuwano H, Shirabe K.　Enhanced karyopherin-α2 expression is associated with carcinogenesis in patients with intraductal papillary mucinous neoplasms.　Pancreatology. 2017 Apr 23. pii: S1424-3903(17)30077-7. doi: 10.1016/j.pan.2017.04.011. [Epub ahead of print]
  • Watanabe A, Araki K, Yokobori T, Altan B, Ishii N, Tsukagoshi M, Kubo N, Saito F, Suzuki H, Kuwano H.　Stathmin 1 promotes the proliferation and malignant transformation of pancreatic intraductal papillary mucinous neoplasms.　Oncol Lett. 2017 Mar;13(3):1783-1788. doi: 10.3892/ol.2017.5603. Epub 2017 Jan 17
  • Ishii N, Araki K, Yokobori T, Watanabe A, Tsukagoshi M, Kubo N, Suzuki H, Saito F, Altan B, Hosouchi Y, Shirabe K, Kuwano H. Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy. Oncol Lett. 2017 May;13(5):3653-3661.
  • Uchiyama H, Shirabe K, Araki K, Sugimachi K, Morita K, Takenaka K, Maehara Y. Left hepatectomy with simultaneous hepatic artery and portal vein reconstructions in the operation for cholangiocarcinoma: the surgical techniques comprised of step-by-step established procedures. Transl Gastroenterol Hepatol. 2017 Apr 28;2:34. doi: 10.21037/tgh.2017.03.16. eCollection 2017.
  • Yamanaka T, Araki K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Kuwano H, Shirabe K. Carcinoma of the Papilla of Vater after Diversion Operation for Pancreaticobiliary Maljunction. Case Rep Gastroenterol. 2017 May 17;11(2):265-270. doi: 10.1159/000462967. eCollection 2017 May-Aug.
  • Tsukagoshi M, Araki K, Saito F, Kubo N, Watanabe A, Igarashi T, Ishii N, Yamanaka T, Shirabe K, Kuwano H.　Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms. Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4667-y. [Epub ahead of print]
  • Ishii N, Araki K, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Kuwano H, Shirabe K. Small cholangiolocellular carcinoma that was difficult to distinguish from cholangiocellular carcinoma: a case report. Surg Case Rep. 2017 Sep 15;3(1):103. doi: 10.1186/s40792-017-0377-0.
  • Araki K, Shirabe K, Watanabe A, Kubo N, Sasaki S, Suzuki H, Asao T, Kuwano H. Risk factors for an additional port in single-incision laparoscopic cholecystectomy in patients with cholecystitis. J Med Invest. 2017;64(3.4):245-249.
  • Yazawa T, Watanabe A, Araki K, Segawa A, Hirai K, Norio Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Hoshino K, Kuwano H, Shirabe K. Complete resection of a huge pancreatic undifferentiated carcinoma with osteoclast-like giant cells.　International Cancer Conference Journal October 2017, Volume 6, Issue 4, pp 193–196.
  • Araki K, Kubo N, Watanabe A, Kuwano H, Shirabe K. Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions.
    Surg Today. 2017 Nov 13. doi: 10.1007/s00595-017-1607-6. Review.
  • Kenichiro Araki, Claudius Conrad.
    Section 2-15: Intraoperative laparoscopic ultrasound for laparoscopic hepatopancreatobiliary surgery. Laparoscopic Liver, Pancreas, and Biliary Surgery, Claudius Conrad, Brice Gayet, eds.
    John Wiley & Sons Ltd, Hoboken(NJ), p231-237, 2017
  • Yamanaka T, Araki K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Kuwano H, Shirabe K. Internal Hernia into the Treitz Fossa after Pancreaticoduodenectomy.
    Case Rep Gastroenterol. 2017 Oct 30;11(3):643-646.
  • Ishii N, Araki K, Yokobori T, Gantumur D, Yamanaka T, Altan B, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Hosouchi Y, Kuwano H, Shirabe K.　Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1.　Oncotarget. 2017 Nov 6;8(68):112636-112646.
  • Shirabe K, Bekki Y, Gantumur D, Araki K, Ishii N, Kuno A, Narimatsu H, Mizokami M.　Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.　J Gastroenterol. 2018 Jan 9. doi: 10.1007/s00535-017-1425-z. [Epub ahead of print] Review
  • Shirabe K, Eguchi S, Okajima H, Hasegawa K, Marubashi S, Umeshita K, Kawasaki S, Yanaga K, Shimada M, Kaido T, Kawagishi N, Taketomi A, Mizuta K, Kokudo N, Uemoto S, Maehara Y; Japanese Liver Transplantation Society.　Current status of surgical incisions used in donors during living related liver transplantation - a nationwide survey in Japan.　Transplantation. 2018 Feb 9. doi: 10.1097/TP.0000000000002126. [Epub ahead of print]
  • Araki K, Kubo N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kuwano H, Shirabe K.　Left Lobe Mobilization Strategy of Right-Sided Major Hepatectomy for Treatment of a Tumor Causing Severe Inferior Vena Cava Compression: A Novel Strategy Using the Modified Liver-Hanging Maneuver.　Ann Surg Oncol. 2018 Feb 14. doi: 10.1245/s10434-018-6362-4. [Epub ahead of print]
  • Watanabe A, Araki K, Harimoto N, Kubo N, Igarashi T, Ishii N, Yamanaka T, Hagiwara K, Kuwano H, Shirabe K.D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.　Int J Clin Oncol. 2018 Mar 24. doi: 10.1007/s10147-018-1271-x. [Epub ahead of print]
  • Watanabe T, Araki K, Ishii N, Igarashi T, Watanabe A, Kubo N, Kuwano H, Shirabe K.　A Surgically Resected Pancreatic Schwannoma with Obstructive Jaundice with Special Reference to Differential Diagnosis from Other Cystic Lesions in the Pancreas. Case Rep Gastroenterol. 2018 Feb 21;12(1):85-91.
  • Hagiwara K, Araki K, Yamanaka T, Ishii N, Igarashi T, Watanabe A, Kubo N, Harimoto N, Kuwano H, Nobusawa S, Aishima S, Shirabe K.　Resected primary mucinous cholangiocarcinoma of the liver.　Surg Case Rep. 2018 May 2;4(1):41. doi: 10.1186/s40792-018-0450-3.
  • Kubo N, Harimoto N, Shibuya K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Araki K, Miyazaki M, Kuwano H, Shirabe K. Successful treatment of isolated bile leakage after hepatectomy combination therapy with percutaneous transhepatic portal embolization and bile duct ablation with ethanol: a case report.　Surg Case Rep. 2018 Jun 19;4(1):61. doi: 10.1186/s40792-018-0463-y.
  • Harimoto N, Yoshizumi T, Inokuchi S, Itoh S, Adachi E, Ikeda Y, Uchiyama H, Utsunomiya T, Kajiyama K, Kimura K, Kishihara F, Sugimachi K, Tsujita E, Ninomiya M, Fukuzawa K, Maeda T, Shirabe K, Maehara Y.　Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma: A Multi-institutional Study.　Ann Surg Oncol. 2018 Jul 26. doi: 10.1245/s10434-018-6672-6. [Epub ahead of print]
  • Harimoto N, Hoshino H, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Shirabe K. Skeletal Muscle Volume and Intramuscular Adipose Tissue Are Prognostic Predictors of Postoperative Complications After Hepatic Resection. Anticancer Res. 2018 Aug;38(8):4933-39.
  • Harimoto N, Hagiwara K, Yamanaka T, Ishii N, Igarashi T, Watanabe A, Kubo N, Araki K, Ikota H, Suyama M, Maki T, Aishima S, Kuwano H, Shirabe K.　Fairly rare clear cell adenocarcinoma mimicking liver cancer: a case report.　Surg Case Rep. 2018 Aug 16;4(1):97. doi: 10.1186/s40792-018-0500-x.
  • Tsukagoshi M, Wada S, Hirono S, Yoshida S, Yada E, Sasada T, Shirabe K, Kuwano H, Yamaue H.Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer. Oncotarget. 2018 Jul 31;9(59):31448-31458. doi: 10.18632/oncotarget.25837. eCollection 2018 Jul 31.
  • Kubo N, Harimoto N, Araki K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Miyazaki M, Yokoo H, Kuwano H, Shirabe K.　The Feature of Solitary Small Nodular Type of Hepatic Epithelioid Hemangioendothelioma.　Case Rep Gastroenterol. 2018 Aug 21;12(2):402-410.
  • Watanabe A, Harimoto N, Araki K, Yoshizumi T, Arima K, Yamashita Y, Baba H, Tetsuya H, Kuwano H, Shirabe K. A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer. J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
  • Ishii N, Araki K, Yokobori T, Hagiwara K, Dorgormaa G, Yamanaka T, Handa T, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Harimoto N, Masamune A, Umezawa K, Kuwano H, Shirabe K.
    Conophylline suppresses pancreatic cancer desmoplasia and cancer-promoting cytokines produced by cancer-associated fibroblasts.
    Cancer Sci. 2018 Oct 24. doi: 10.1111/cas.13847.
  • Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Yoshizumi T, Shirabe K.
    Absolute Neutrophil Count Predicts Postoperative Prognosis in Mass-forming Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2019 Feb;39(2):941-947. doi: 10.21873
  • Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Tomonaga H, Higuchi T, Tsushima Y, Shirabe K.
    Impact of Metabolic Parameters of 18F-Fluorodeoxyglucose Positron-emission Tomography After Hepatic Resection in Patients With Intrahepatic Cholangiocarcinoma.
    Anticancer Res. 2019 Feb;39(2):971-977. doi: 10.21873
  • Hoshino K, Harimoto N, Muranushi R, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Yokobori T, Shirabe K.
    Successful resection of intrahepatic cholangiocarcinoma with idiopathic thrombocytopenic purpura using thrombopoietin receptor agonist: a case report.
    Surg Case Rep. 2019 Apr 10;5(1):56. doi: 10.1186/s40792-019-0619-4.
  • Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Harimoto N, Ikota H, Shibuya K, Miyazaki M, Shirabe K.
    Hepatic pleomorphic leiomyosarcoma after surgery for gastric gastrointestinal stromal tumor: a case report.
    Surg Case Rep. 2019 Apr 16;5(1):62. doi: 10.1186/s40792-019-0622-9.
  • Igarashi T, Harimoto N, Nobusawa S, Yoshida Y, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Yokobori T, Yokoo H, Shirabe K.
    Evaluation of KRAS Mutation Status in a Patient With Concomitant Pancreatic Neuroendocrine Neoplasm and Intraductal Papillary Mucinous Neoplasm.
    Pancreas. 2019 May/Jun;48(5):e34-e35. doi: 10.1097/MPA.
  • Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.
    Significance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor.
    Pancreas. 2019 Jul 1. doi: 10.1097
  • Ishii N, Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Yamanaka T, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Shirabe K. Preoperative M2BPGi level predicts postoperative ascites in patients with hepatic resection for hepatocellular carcinoma.
    Hepatol Res. 2019 Jul 24. doi: 10.1111
  • Harimoto N, Hoshino K, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Suzuki H, Arakawa K, Hirai K, Fukazawa T, Ikota H, Shirabe K.
    Prognostic significance of neutrophil-lymphocyte ratio in resectable pancreatic neuroendocrine tumors with special reference to tumor-associated macrophages. Pancreatology. 2019 Aug 7. S1424-3903(19)30684-2. doi: 10.1016
  • Hagiwara K, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Gantumur D, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Hosouchi Y, Shirabe K.
    High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer. Ann Surg Oncol. 2019 Aug 28. doi: 10.1245/s10434-019-07708-x.
  • Araki K, Harimoto N, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.
    Optimal indications for an intercostal port for the superior segments in laparoscopic partial liver resection.
    Asian J Endosc Surg. 2019 Aug 29. doi: 10.1111/ases.12753.
  • Araki K, Harimoto N, Kubo N, Watanabe A, Igarashi T, Tsukagoshi M, Ishii N, Tsushima Y, Shirabe K.
    Functional remnant liver volumetry using Gd-EOB-DTPA-enhanced magnetic resonance imaging (MRI) predicts post-hepatectomy liver failure in resection of more than one segment.
    HPB (Oxford). 2019 Aug 30. pii: S1365-182X(19)30687-2. doi: 10.1016/j.hpb.2019.08.002.
  • Araki K, Harimoto N, Shirabe K.
    Global standardization of laparoscopic liver resection and challenges for the future.
    Hepatobiliary Surg Nutr. 2019 Aug;8(4):386-388. doi: 10.21037/hbsn.2019.02.08.
  • Watanabe A, Harimoto N, Yokobori T, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Handa T, Oyama T, Higuchi T, Shirabe K.
    FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.
    Int J Clin Oncol. 2019 Oct 14. doi: 10.1007/s10147-019-01557-0.
  • Araki K, Harimoto N, Muranushi R, Hoshino K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.
    Evaluation of the use of intraoperative real-time virtual sonography with sonazoid enhancement for detecting small liver metastatic lesions after chemotherapy in hepatic resection.
    J Med Invest. 2019;66(3.4):319-323.
  • Igarashi T, Harimoto N, Matsumura N, Sugiyama M, Araki K, Yokobori T, Kosone T, Takagi H, Aishima S, Yokoo H, Shirabe K.
    Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.
    Surg Case Rep. 2019 Nov 6;5(1):170. doi: 10.1186/s40792-019-0705-7.
  • Hagiwara K, Harimoto N, Shirabe K.
    ASO Author Reflections: Clinical Significance of Large Tenascin C Splice Variants and Annexin A2 for Pancreatic Cancer.
    Ann Surg Oncol. 2019 Nov 22. doi: 10.1245/s10434-019-08009-z.
  • Igarashi T, Shimizu K, Usui K, Yokobori T, Ohtaki Y, Nakazawa S, Obayashi K, Yajima T, Nobusawa S, Ohkawa T, Katoh R, Motegi Y, Ogawa H, Harimoto N, Ichihara T, Mitani Y, Yokoo H, Mogi A, Shirabe K.
    Significance of RAS mutations in pulmonary metastases of patients with colorectal cancer.
    Int J Clin Oncol. 2019 Nov 26. doi: 10.1007/s10147-019-01582-z.
  • Kubo N, Shirabe K.
    Treatment strategy for isolated bile leakage after hepatectomy: Literature review.
    Ann Gastroenterol Surg. 2019 Dec 5;4(1):47-55.
  • Igarashi T, Harimoto N, Matsumura N, Sugiyama M, Araki K, Yokobori T, Kosone T, Takagi H, Aishima S, Yokoo H, Shirabe K Fairly rare small-diameter hepatocellular carcinoma with right adrenal gland metastasis having an inferior vena cava tumor thrombus: a case report.
    Surg Case Rep. 2019 Nov 6;5(1):170. doi: 10.1186/s40792-019-0705-7.
  • Harimoto N, Muranushi R, Hoshino K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Shirabe K.
    Albumin-Indocyanine Green Evaluation (ALICE) grade predicts bile leakage after hepatic resection.
    Surg Today. 2020 Jan 14. doi: 10.1007/s00595-020-01955-2.
  • Yamanaka T, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Handa T, Ishii N, Tsukagoshi M, Igarashi T, Tanaka H, Watanabe A, Kubo N, Araki K, Shirabe K.
    Nintedanib inhibits intrahepatic cholangiocarcinoma aggressiveness via suppression of cytokines extracted from activated cancer-associated fibroblasts.
    Br J Cancer. 2020 Feb 4.
  • Tsukagoshi M, Yokobori T, Yajima T, Maeno T, Shimizu K, Mogi A, Araki K, Harimoto N, Shirabe K, Kaira K.
    Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer. Medicine (Baltimore). 2020 Feb;99(7):e19059.
  • Kubo N, Harimoto N, Araki K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Shirabe K.
    Hepatic resection for the right hepatic vein drainage area with indocyanine green fluorescent imaging navigation.
    J Hepatobiliary Pancreat Sci 2020
  • Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Yamanaka T, Hagiwara K, Hoshino K, Muranushi R, Shirabe K.
    D-Dimer Could Be a Surrogate Postoperative Prognostic Marker of Resectable Pancreatic Cancer. Pancreas. 2020 Apr;49(4):e36-e38.
  • Watanabe A, Yoshizumi T, Harimoto N, Kogure K, Ikegami T, Harada N, Itoh S, Takeishi K, Mano Y, Yoshiya S, Morinaga A, Araki K, Kubo N, Mori M, Shirabe K.
    Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Apr 26. doi: 10.1002/bjs.11602.
  • Hoshino K, Harimoto N, Muranushi R, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Tomomasa R, Nobusawa S, Aishima S, Nakashima O, Shirabe K. Unclassified hepatocellular adenoma with histological brown pigment deposition and serum PIVKA-II level elevation: a case report. Surg Case Rep. 2020 May 7;6(1):94. doi: 10.1186/s40792-020-00853-6.
  • Watanabe A, Harimoto N, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Kubo N, Araki K, Suzuki A, Hara K, Shirabe K. Rare metastatic pancreatic tumors from lung cancer with cystic changes resembling intraductal papillary mucinous neoplasm: a case report. Surg Case Rep. 2020 May 28;6(1):117. doi: 10.1186/s40792-020-00870-5.
  • Kubo N, Yokobori T, Takahashi R, Ogawa H, Gombodorj N, Ohta N, Ohno T, Saeki H, Shirabe K, Asao T.
    An abdominal spacer that does not require surgical removal and allows drainage of abdominal fluids in patients undergoing carbon ion radiotherapy.
    PLoS One. 2020 Jun 10;15(6):e0234471. doi: 10.1371
  • Tsukagoshi M, Harimoto N, Araki K, Kubo N, Watanabe A, Igarashi T, Ishii N, Yajima T, Sano T, Shirabe K.
    Liver metastasis from papillary thyroid carcinoma treated by laparoscopic hepatectomy 43 years after resection of the primary tumor: a case report.
    Surg Case Rep. 2020 Jun 18;6(1):142. doi: 10.1186/s40792-020-00906-w.
  • Araki K, Harimoto N, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Tsushima Y, Shirabe K.
    Efficiency of regional functional liver volume assessment using Gd-EOB-DTPA-enhanced magnetic resonance imaging for hepatocellular carcinoma with portal vein tumor thrombus.
    Surg Today. 2020 Jul 1. doi: 10.1007/s00595-020-02062-y
  • Dolgormaa G, Harimoto N, Ishii N, Yamanaka T, Hagiwara K, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Handa T, Yokobori T, Oyama T, Kuwano H, Shirabe K.
    Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
    Br J Cancer. 2020 Jul 6. doi: 10.1038/s41416-020-0971-y.
  • Harimoto N, Araki K, Hoshino K, Muranushi R, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Tomonaga H, Higuchi T, Tsushima Y, Ikota H, Shirabe K.
    Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors. World J Surg. 2020 Aug 14. doi: 10.1007/s00268-020-05736-3.
  • Harimoto N, Araki K, Ishii N, Muranushi R, Hoshino K, Hagiwara K, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K.　Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma.
    Anticancer Res. 2020 Aug;40(8):4343-4349.
  • Harimoto N, Araki K, Muranushi R, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shibuya K, Miyazaki M, Kawanaka H, Shirabe K.　Multimodal approach to portal hypertension and gastric varices before hepatic resection for hepatocellular carcinoma: a case report.
    Surg Case Rep. 2020 Jul 31;6(1):190.
  • Harimoto N, Araki K, Hoshino K, Muranushi R, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Tomonaga H, Higuchi T, Tsushima Y, Ikota H, Shirabe K.
    Diffusion-Weighted MRI Predicts Lymph Node Metastasis and Tumor Aggressiveness in Resectable Pancreatic Neuroendocrine Tumors.
    World J Surg. 2020 Aug 14. doi: 10.1007/s00268-020-05736-3.
  • Watanabe A, Harimoto N, Kogure K, Shirabe K.
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 16. doi: 10.1002/bjs.11825.
  • Watanabe A, Harimoto N, Kogure K, Shirabe K.
    Author response to: Comment on: Right hepatic venous system variation in living donors: a three-dimensional CT analysis.
    Br J Surg. 2020 Sep 29. doi: 10.1002/bjs.11983.
  • Hagiwara K, Harimoto N, Araki K, Watanabe A, Kubo N, Nakazawa S, Yajima T, Uchida N, Shirabe K.
    Long-term survival of two patients with pancreatic cancer after resection of liver and lung oligometastases: a case report. Surg Case Rep. 2020 Dec 7;6(1):309.
  • Igarashi T, Harimoto N, Matsui Y, Muranushi R, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Saito S, Shirabe K. Association between intraoperative and postoperative epidural or intravenous patient-controlled analgesia and pancreatic fistula after distal pancreatectomy.
    Surg Today. 2021 Feb;51(2):276-284.
  • Muranushi R, Araki K, Harimoto N, Yokobori T, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Aishima S, Shirabe K.
    Unclassified hepatocellular adenoma with beta-catenin mutation: a case report.
    Surg Case Rep. 2021 Feb 12;7(1):46.
  • Yamanaka T, Harimoto N, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Handa T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Umezawa K, Shirabe K..
    Conophylline inhibits hepatocellular carcinoma by inhibiting activated cancer-associated fibroblasts through suppression of G Protein-Coupled Receptor 68.
    Mol Cancer Ther. 2021 Mar 15:molcanther.0150.2020. doi: 10.1158/1535-7163.
  • Gantumur D, Harimoto N, Muranushi R, Hoshino K, Batbayar C, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Araki K, Yokobori T, Aishima S, Shirabe K.
    Hepatic Stellate Cell as a Mac-2-binding Protein-producing Cell in Patients with Liver Fibrosis.
    Hepatol Res. 2021 Apr 20. doi: 10.1111/hepr.13648.
  • Watanabe A, Harimoto N, Araki K, Kubo N, Igarashi T, Tsukagoshi M, Ishii N, Hirai K, Tanaka H, Mochida Y, Kogure N, Higuchi T, Shirabe K.
    FDG-PET for preoperative evaluation of tumor invasion in ampullary cancer: A retrospective analysis.
    J Surg Oncol. 2021 May 12. doi: 10.1002/jso.26513.
  • Muranushi R, Araki K, Yokobori T, Chingunjav B, Hoshino K, Dolgormaa G, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Harimoto N, Shimoda Y, Sano R, Oyama T, Saeki H, Shirabe K
    High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence.
    Cancer Sci. 2021 Jun 3. doi: 10.1111/cas.15004.
  • Tsukagoshi M, Harimoto N, Araki K, Kubo N, Watanabe A, Igarashi T, Ishii N, Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy.
    Int J Clin Oncol. 2021 Jun 4. doi: 10.1007/s10147-021-01958-0.
  • Seki T, Watanabe A, Harimoto N, Shirabe K.
    Systematic review of resectable intraductal tubulopapillary neoplasm with special reference to recurrence patterns.
    Surg Today. 2021 Jul 1. doi: 10.1007/s00595-021-02324-3.
  • Araki K, Harimoto N, Shibuya K, Kubo N, Watanabe A, Igarashi T, Tsukagoshi M, Ishii N, Tsushima Y, Shirabe K.
    Prediction with functional liver volume assessment to achieve the resection limit after portal vein embolization in patients scheduled major hepatectomy.
    HPB (Oxford). 2021 Jun 10:S1365-182X(21)00164-7.
  • Harimoto N, Araki K, Hagiwara K, Yamanaka T, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Kubo N, Shirabe K
    Gastrectomy history as a predictor of post-hepatectomy complications.
    Surg Today. 2021 Aug 24. doi: 10.1007/s00595-021-02366-7.
  • Tsukagoshi M, Harimoto N, Araki K, Kubo N, Watanabe A, Igarashi T, Ishii N, Yamanaka T, Hagiwara K, Hoshino K, Muranushi R, Yajima T, Shirabe K.
    Skeletal Muscle Loss and Octogenarian Status Are Associated with S-1 Adjuvant Therapy Discontinuation and Poor Prognosis after Pancreatectomy.
    Cancers (Basel). 2021 Aug 15;13(16):4105. doi: 10.3390/cancers13164105
  • Harimoto N, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Shirabe K.
    Direct Bilirubin in Drainage Fluid 3 days after Hepatectomy Is Useful for Detecting Severe Bile Leakage.
    Eur Surg Res. 2021 Aug 25:1-7. doi: 10.1159/000518267.
  • Igarashi T, Harimoto N, Muranushi R, Yamanaka T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Watanabe A, Kubo N, Araki K, Saito S, Shirabe K.
    Does intraoperative and postoperative analgesia cause bile leakage after hepatectomy?
    Surg Today. 2021 Sep 20. doi: 10.1007/s00595-021-02377-4.
  • Harimoto N, Araki K, Muranushi R, Hoshino K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Shirabe K.
    Significance of zinc deficiency in patients with hepatocellular carcinoma undergoing hepatic resection.
    Hepatol Res. 2021 Nov 10. doi: 10.1111/hepr.13730.
  • Harimoto N, Itoh S, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Araki K, Yoshizumi T, Shirabe K. Mac-2 Binding Protein Glycosylation Isomer as a Prognostic Marker for Hepatocellular Carcinoma With Sustained Virological Response.
    Anticancer Res. 2022 Jan;42(1):245-251. doi: 10.21873/anticanres.15479.
  • Hagiwara K, Harimoto N, Yamanaka T, Ishii N, Yokobori T, Tsukagoshi M, Watanabe A, Araki K, Yoshizumi T, Shirabe K.
    New Liver-Regeneration Molecular Mechanism Involving Hepatic Stellate Cells, Kupffer Cells, and Glucose-Regulated Protein 78 as a New Hepatotrophic Factor.
    J Hepatobiliary Pancreat Sci. 2022 May 18. doi: 10.1002/jhbp.1183.
  • Harimoto N, Araki K, Yamanaka T, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Takizawa M, Yokobori T, Shirabe K.
    The ratio of creatinine and cystatin C estimated glomerular filtration rates as a surrogate marker in patients with hepatocellular carcinoma undergoing hepatic resection.
    J Hepatobiliary Pancreat Sci. 2022 May 11. doi: 10.1002/jhbp.1164.
  • Araki K, Shibuya K, Harimoto N, Watanabe A, Tsukagoshi M, Ishii N, Ikota H, Yokobori T, Tsushima Y, Shirabe K.
    A prospective study of sequential hepatic vein embolization after portal vein embolization in patients scheduled for right-sided major hepatectomy: results of feasibility and surgical strategy using functional liver assessment.
    J Hepatobiliary Pancreat Sci. 2022 Jun 23.
  • Kubo N, Yazawa S, Yokobori T, Sano R, Eguchi H, Kobayashi S, Akita H, Mitsufuji S, Yamashita YI, Nakao Y, Fujii T, Okumura T, Shibuya K, Hoshino Y, Yamada S, Hayashi M, Shimokawa M, Shirabe K. The malignant potential of pancreatic intraductal papillary mucinous neoplasm is reflected in expression levels of fucosylated glycans in α1 -acid glycoprotein. J Hepatobiliary Pancreat Sci. 2022 Jul 1. doi: 10.1002/jhbp.1208.
  • Seki T, Tsukagoshi M, Harimoto N, Araki K, Watanabe A, Ishii N, Hagiwara K, Hoshino K, Muranushi R, Kakizaki S, Ogawa Y, Handa H, Shirabe K.
    Laparoscopic hepatectomy for hepatocellular carcinoma in a patient with congenital factor V deficiency: a case report.
    Surg Case Rep. 2022 Oct 22;8(1):202. doi: 10.1186/s40792-022-01559-7.
  • Yamanaka T, Harimoto N, Muranushi R, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Watanabe A, Araki K, Shirabe K.
    Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy.
    Anticancer Res. 2022 Dec;42(12):5971-5976. doi: 10.21873/anticanres.16107.
  • Araki K, Harimoto N, Shibuya K, Watanabe A, Tsukagoshi M, Ishii N, Hagiwara K, Muranushi R, Hoshino K, Seki T, Shirabe K.
    Significance of Skeletal Muscle Loss in Liver Hypertrophy in Patients Undergoing Portal Vein Embolization Before Major Hepatectomy: Assessment With Body Composition and Nutritional Indicators.
    Anticancer Res. 2023 Jan;43(1):209-216. doi: 10.21873/anticanres.16151.
  • Watanabe A, Harimoto N, Araki K, Tsukagoshi M, Ishii N, Hagiwara K, Yamanaka T, Hoshino K, Muranushi R, Shirabe K.
    Abdominal aortic calcification volume (AACV) is a predictive factor for postoperative complications associated with biliary tract cancer.
    Surg Today. 2023 Feb;53(2):207-213. doi: 10.1007/s00595-022-02621-5.
  • Ishii N, Harimoto N, Seki T, Muranushi R, Hagiwara K, Tsukagoshi M, Watanabe A, Yoshida Y, Araki K, Shirabe K.
    Autotaxin is a novel surrogate marker for oxaliplatin-related sinusoidal
    obstruction syndrome in patients with colorectal liver metastasis.
    Hepatol Res. 2023 Mar 22. doi: 10.1111/hepr.13901. Online ahead of print.
    ＜https://pubmed.ncbi.nlm.nih.gov/36946410/＞
  • Batbayar C, Ishii N, Harimoto N, Yokobori T, Saito H, Gantumur D, Gombodorj N, Erkhem-Ochir B, Muranushi R, Hoshino K, Yamanaka T, Hagiwara K, Tsukagoshi M, Watanabe A, Araki K, Hosouchi Y, Shirabe K.
    High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer.
    Int J Clin Oncol. 2023 Apr 29. doi: 10.1007/s10147-023-02342-w. Online ahead of print.
  • Araki K, Harimoto N, Watanabe A, Tsukagoshi M, Ishii N, Hagiwara K, Muranushi R, Hoshino K, Seki T, Shirabe K.
    Laparoscopic Liver Resection Procedure Attenuates Organ-space Surgical Site Infection Compared With Open Procedure: A Propensity Score-matched Analysis.
    Anticancer Res. 2023 May;43(5):2273-2280. doi: 10.21873/anticanres.16391.
  • Tsukagoshi M, Watanabe A, Araki K, Ishii N, Hagiwara K, Hoshino K, Muranushi R, Harimoto N, Takizawa M, Shirabe K.
    Usefulness of serum creatinine and cystatin C ratio as a screening tool for predicting prognosis in patients with pancreatic cancer.
    Ann Gastroenterol Surg. 2023 Apr 25;7(5):784-792. doi: 10.1002/ags3.12671.
    eCollection 2023 Sep.
  • Watanabe A, Harimoto N, Saito H, Kawabata-Iwakawa R, Seki T, Muranushi R, Hoshino K, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Ikota H, Ishige T, Mimori K, Shirabe K.
    Fibrolamellar hepatocellular carcinoma: a case report and gene analysis.
    Surg Case Rep. 2023 Sep 20;9(1):168. doi: 10.1186/s40792-023-01751-3.
  • Hagiwara K, Watanabe A, Harimoto N, Araki K, Yokobori T, Muranushi R, Hoshino K, Ishii N, Tsukagoshi M, Shirabe K.
    Liver regeneration after hepatectomy is significantly suppressed in a muscular atrophy mouse model.
    J Hepatobiliary Pancreat Sci. 2023 Nov 1. doi: 10.1002/jhbp.1386. Online ahead of print.
  • Ishii N, Harimoto N, Seki T, Muranushi R, Hagiwara K, Hoshino K, Tsukagoshi M, Watanabe A, Igarashi T, Shibuya K, Araki K, Shirabe K.
    The impact of lymphangiograpy on chyle leakage treatment duration after pancreatic surgery.
    Surg Today. 2023 Dec 8. doi: 10.1007/s00595-023-02777-8. Online ahead of print.
  • Tsukagoshi M, Harimoto N, Araki K, Ishii N, Hagiwara K, Hoshino K, Yanagisawa K, Ogawa Y, Handa H, Shirabe K.
    Laparoscopic hepatectomy for hepatocellular carcinoma in patients with hemophilia A and B: a report of two cases.
    Clin J Gastroenterol. 2023 Dec;16(6):884-890. doi: 10.1007/s12328-023-01854-2. Epub 2023 Sep 5.
  • Harimoto N, Tsukagoshi M, Okuyama T, Hoshino K, Hagiwara K, Kawai S, Ishii N, Igarashi T, Araki K, Shirabe K.
    Significance of malnutrition defined with Global Leadership Initiative on Malnutrition criteria in patients with hepatocellular carcinoma after hepatic resection.
    Hepatol Res. 2023 Dec;53(12):1235-1248. doi: 10.1111/hepr.13959. Epub 2023 Sep 5.
  • Hoshino K, Nakazawa S, Yokobori T, Hagiwara K, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Harimoto N, Tokunaga F, Shirabe K.
    RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation.
    Sci Rep. 2024 Jan 3;14(1):346. doi: 10.1038/s41598-023-50594-3.PMID: 38172174 Free PMC article.
  • Harimoto N, Tsukagoshi M, Seki T, Hoshino K, Hagiwara K, Ishii N, Igarashi T, Araki K, Haruki K, Ikegami T, Shirabe K.
    Predictors for early recurrence beyond up-to-7 or distant metastasis after hepatocellular carcinoma resection: proposal for borderline resectable HCC.
    Int J Clin Oncol. 2024 Feb;29(2):195-204. doi: 10.1007/s10147-023-02434-7.
    Epub 2024 Jan 16.
  • Watanabe A, Harimoto N, Araki K, Igarashi T, Tsukagoshi M, Ishii N, Hagiwara K, Tsunekawa K, Murakami M, Shirabe K.
    Perioperative pancreaticoduodenectomy management strategy focusing on postoperative early drain colonization.
    Surg Today. 2024 Mar 19. doi: 10.1007/s00595-024-02810-4. Online ahead of print.PMID: 38502211
  • Fukushima R, Harimoto N, Kawai S, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Tomonaga H, Higuchi T, Shirabe K.
    Total lesion glycolysis by 18 F-fluorodeoxyglucose positron emission tomography predicts tumor aggressiveness in patients with extrahepatic bile duct carcinoma.
    J Hepatobiliary Pancreat Sci. 2024 Mar 11. doi: 10.1002/jhbp.1421. Online ahead of print.PMID: 38465467
  • Yamanaka T, Araki K, Yokobori T, Muranushi R, Hoshino K, Hagiwara K, Gantumur D, Ishii N, Tsukagoshi M, Watanabe A, Harimoto N, Masamune A, Uojima H, Mizokami M, Ito K, Shirabe K.
    Potential of Mac-2-binding protein glycan isomer as a new therapeutic target in pancreatic cancer.
    Cancer Sci. 2024 Feb 6. doi: 10.1111/cas.16087. Online ahead of print.PMID: 38321872
  • Harimoto N, Igarashi T, Okuyama T, Hoshino K, Hagiwara K, Kawai S, Ishii N, Tsukagoshi M, Araki K, Shirabe K.
    Preoperative zinc status predicts the occurrence and healing time of pancreatic fistula after distal pancreatectomy. World J Surg. 2024 Jan;48(1):186-192. doi: 10.1002/wjs.12011. Epub 2023 Dec 11. PMID: 38686792.
  • Tsukagoshi M, Araki K, Igarashi T, Ishii N, Kawai S, Hagiwara K, Hoshino K, Seki T, Okuyama T, Fukushima R, Harimoto N, Shirabe K.
    Lower Geriatric Nutritional Risk Index and Prognostic Nutritional Index Predict Postoperative Prognosis in Patients with Hepatocellular Carcinoma.
    Nutrients. 2024 Mar 25;16(7):940. doi: 10.3390/nu16070940. PMID: 38612974; PMCID: PMC11013710.
  • Seki T, Osone K, Ogawa H, Okada T, Shiraishi T, Sohda M, Shirabe K, Saeki H.
    Damage to the Descending Colon after Endoscopic Balloon Dilatation following a Minor Traffic Accident in a Patient with Crohn's Disease: A Case Report. Case Rep Gastroenterol. 2024 Apr 25;18(1):244-251. doi: 10.1159/000537973. PMID: 38665146; PMCID: PMC11045211.
  • Fukushima R, Harimoto N, Okuyama T, Seki T, Hoshino K, Hagiwara K, Kawai S, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Shirabe K.
    Impact of the serum creatinine and cystatin C ratio for prediction of sarcopenia and prognosis in biliary tract cancer. Int J Clin Oncol. 2024 Apr 29. doi: 10.1007/s10147-024-02539-7. Epub ahead of print. PMID: 38683456.
  • Muranushi R, Harimoto N, Seki T, Hagiwara K, Hoshino K, Ishii N, Tsukagoshi M, Igarashi T, Watanabe A, Araki K, Shirabe K.
    Early drain removal after hepatectomy based on bile leakage prediction using drainage fluid volume and direct bilirubin level. Hepatol Res. 2024 May 8. doi: 10.1111/hepr.14055. Epub ahead of print. PMID: 38717068.
  • Fukushima R, Harimoto N, Okuyama T, Seki T, Hoshino K, Hagiwara K, Kawai S, Ishii N, Tsukagoshi M, Igarashi T, Araki K, Tomonaga H, Higuchi T,Shimokawa M, Shirabe K. New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm. Int J Clin Oncol. 2024
    Aug;29(8):1182-1190. doi: 10.1007/s10147-024-02553-9. Epub 2024 May 20.
    PMID: 38769190.
  • Tsukagoshi M, Araki K, Shirabe K. Pancreatic cancer and sarcopenia: a narrative review of the current status. Int J Clin Oncol. 2024
    Aug;29(8):1055-1066. doi: 10.1007/s10147-024-02576-2. Epub 2024 Jul 2.
    PMID: 38954075.
  • Araki K, Watanabe A, Harimoto N, Igrashi T, Tsukagoshi M, Ishii N, Kawai S, Hagiwara K, Hoshino K, Shirabe K. Advantages of laparoscopic segmentectomy of the liver using ICG fluorescent navigation by the negative staining method: A comparison with open procedure. Ann Gastroenterol Surg.
    2024 Mar 7;8(4):691-700. doi: 10.1002/ags3.12786. PMID: 38957559; PMCID: PMC11216779.
  • Yamanaka T, Araki K, Suzuki H, Osawa H, Shirabe K. Intraoperative severe gastric venous congestion during total pancreatectomy with replaced common hepatic artery: a case report. Surg Case Rep. 2024 Aug 8;10(1):184. doi: 10.1186/s40792-024-01983-x. PMID: 39112680.